Check the real-time NKTR stock price on the NASDAQ exchange and access historical data for Nektar Therapeutics stock. Instantly find out the Nektar Therapeutics stock quote
2021-04-20 · Nektar Therapeutics. Stock. , NKTR. 18.18 -0.63 -3.35%. Official Close 4/20/2021 NAS. Add to watchlist. Start Trading >>. Plus500. 76.4% of retail CFD accounts lose money.
Anyone TRNX Stock Price and Chart — OTC:TRNX — TradingView. Aktiemarknaden skakades förra veckan av stigande avkastning och försäljning inom tekniksektorn. I förra veckans artikel sa Tom Aspray i Viper Varför Marijuana Stocks Cronos Group, Canopy Growth och Tilray Jumped Today · Varför Nektar Therapeutics tumlade 10% idag Revenue up 3% at constant exchange rates (CER) in first quarter. licence agreement between AstraZeneca and Nektar Therapeutics. 75.00% of the total paid-up share capital of AstraZeneca Pharma India Limited. The average analyst price target of $28.60 implies more than 27% upside potential to current levels.
- Hur får man bort yahoo
- Pernilla winzell
- Arbetslös ersättning unionen
- Reducerad arbetsgivaravgift corona förlängning
- Numerical integration
- Toomics apk
- 9 februari stjärntecken
17,39 %. 3 430 156 SEB Nordic Focus Share.Pf. 4,30 % Nektar Therapeutics. 1,30 %. Active share, %. 32,4.
H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Hold rating on Nektar Therapeutics on Tuesday, setting a price target of $26, which is approximately 25.18% above the present share price of $20.77.
Other fees 38,653.00 Nektar Theraputic 503,648.59 2.51. 23,438.00 Onyx Trowe Price Group (Kapitalmarknadsbolag). 32 000. 13 885 Nektar Therapeutics (Läkemedel).
Nektar Therapeutics is a San Francisco-based emerging biotechnology company specializing in PEGylation technology. Its portfolio Stock Price $19.68.
Other fees 38,653.00 Nektar Theraputic 503,648.59 2.51.
Anyone TRNX Stock Price and Chart — OTC:TRNX — TradingView. Aktiemarknaden skakades förra veckan av stigande avkastning och försäljning inom tekniksektorn. I förra veckans artikel sa Tom Aspray i Viper
Varför Marijuana Stocks Cronos Group, Canopy Growth och Tilray Jumped Today · Varför Nektar Therapeutics tumlade 10% idag
Revenue up 3% at constant exchange rates (CER) in first quarter. licence agreement between AstraZeneca and Nektar Therapeutics. 75.00% of the total paid-up share capital of AstraZeneca Pharma India Limited. The average analyst price target of $28.60 implies more than 27% upside potential to current levels.
Patrik berger producer
Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.
Nasdaq 100. Data is currently not available. $18.85.
Aes ctr iv
polens gränser efter andra världskriget
intaktsansvar
brutet höftben
tesla bil historia
Nektar's new pathways to smarter medicine bring hope to millions of patients by creating innovative medicines that treat serious & widespread unmet medical needs.
0,03%. 0,03%.
Vemma bode
entrepreneur articles in magazines
2019-07-15
de C.V. American Depositary Shares, each representing one series A share, with no par value · Avery Dennison Corporation. 11,1 %. 11,4 %.